LIGAND PHARMACEUTICALS INCORPORATED Total Shareholder Rtn Amt
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Total Shareholder Rtn Amt of $279.02 for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-21.
Financial Statements › Notes
ecd:TotalShareholderRtnAmt · last filed 2026-04-21
| Period end | Total Shareholder Rtn Amt 12 month |
|---|---|
| 2025-12-31 | $279.02 DEF 14A · filed 2026-04-21 |
| 2024-12-31 | $158.15 DEF 14A · filed 2026-04-21 |
| 2023-12-31 | $105.43 DEF 14A · filed 2026-04-21 |
| 2022-12-31 | $98.62 DEF 14A · filed 2026-04-21 |
| 2021-12-31 | $155.21 DEF 14A · filed 2026-04-21 |